Company Filing History:
Years Active: 2016-2019
Title: Maria Desantis: Innovator in Epidermal Radionuclide Therapy
Introduction
Maria Desantis is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of medical technology, particularly in the area of epidermal radionuclide therapy. With a total of 3 patents to her name, her work focuses on innovative methods for treating skin tumors.
Latest Patents
One of her latest patents is a layer structure for epidermal radionuclide therapy. This invention discloses a layer structure designed for brachytherapy, which includes a proximal adherent layer for application on the skin surface, a flexible transparent carrier layer, and at least one radionuclide-containing emission layer. The design ensures that the layers are essentially transparent to beta and gamma radiation, making it particularly suitable for treating basal-cell carcinoma (BCC) and squamous cell carcinoma (SCC). Another notable patent involves a method of treating skin tumors using a tailor-made radioactive source. This method includes defining the treatment area, applying a protective layer, and using a specialized radioactive source to target the lesion while sparing healthy skin.
Career Highlights
Maria Desantis is currently associated with Oncobeta International GmbH, where she continues to develop her innovative ideas. Her work has the potential to revolutionize the treatment of complex skin lesions, providing new hope for patients suffering from skin cancers.
Collaborations
She collaborates with notable colleagues such as Cesidio Cipriani and Oliver Buck, contributing to a dynamic team focused on advancing medical technology.
Conclusion
Maria Desantis stands out as a leading inventor in the field of epidermal radionuclide therapy. Her innovative patents and dedication to improving cancer treatment highlight her significant impact on medical technology.